Maintenance dosing of intravenous Bevacizumab in the treatment of severe HHT related bleeding and refractory anemia

Iyer Vivek N.; Apala Dinesh R.; Kotecha Aditya; Pannu Bibek S.; Brinjikji Waleed; Leise Michael D.; Kamath Patrick S.; Misra Sanjay; Begna Kebede H.; Cartin-Ceba Rodrigo; DuBrock Hillary M.; Krowka Michael J.; Swanson Karen L.; Pruthi Rajiv K.

首页> 外文期刊>Angiogenesis >Maintenance dosing of intravenous Bevacizumab in the treatment of severe HHT related bleeding and refractory anemia

【24h】

Maintenance dosing of intravenous Bevacizumab in the treatment of severe HHT related bleeding and refractory anemia

机译：静脉内贝伐单抗治疗严重HHT相关出血和难治性贫血的维持给药

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Angiogenesis》 |2018年第1期|共1页
作者
Iyer Vivek N.; Apala Dinesh R.; Kotecha Aditya; Pannu Bibek S.; Brinjikji Waleed; Leise Michael D.; Kamath Patrick S.; Misra Sanjay; Begna Kebede H.; Cartin-Ceba Rodrigo; DuBrock Hillary M.; Krowka Michael J.; Swanson Karen L.; Pruthi Rajiv K.;
展开▼
作者单位

Mayo Clin Div Pulm &

Crit Care Med Rochester MN USA;

Mayo Clin Div Pulm &

Crit Care Med Rochester MN USA;

Mayo Clin Div Pulm &

Crit Care Med Rochester MN USA;

Mayo Clin Div Pulm &

Crit Care Med Rochester MN USA;

Mayo Clin Dept Radiol Rochester MN USA;

Mayo Clin Div Gastroenterol &

Hepatol Rochester MN USA;

Mayo Clin Div Gastroenterol &

Hepatol Rochester MN USA;

Mayo Clin Div Hematol Rochester MN USA;

Mayo Clin Div Pulm Med Scottsdale AZ USA;

Mayo Clin Div Pulm &

Crit Care Med Rochester MN USA;

Mayo Clin Div Pulm &

Crit Care Med Rochester MN USA;

Mayo Clin Div Pulm Med Scottsdale AZ USA;

Mayo Clin Div Hematol Rochester MN USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
入库时间 2022-08-20 01:01:48

相似文献

外文文献
中文文献
专利

1. Maintenance dosing of intravenous Bevacizumab in the treatment of severe HHT related bleeding and refractory anemia [J] . Iyer Vivek N., Apala Dinesh R., Kotecha Aditya, Angiogenesis . 2018,第1期

机译：静脉内贝伐单抗治疗严重HHT相关出血和难治性贫血的维持给药
2. A standardized treatment protocol of Intravenous Bevacizumab for refractory HHT related epistaxis and gastrointestinal bleeding [J] . Iyer Vivek N., Apala Dinesh R., Pannu Bibek S., Angiogenesis . 2018,第1期

机译：用于难治性HHT相关的existaxis和胃肠道出血的静脉内贝伐单抗的标准化治疗方案
3. Experience with bevacizumab as treatment in HHT patients with severe hepatic affection and refractory anemia: ambispective cohort study [J] . Vazquez C., Ferraris A., Tentoni N., Angiogenesis . 2019,第4期

机译：Bevacizumab的经验作为HHT患者严重肝脏感情和难治性贫血患者的治疗方法：公共队列队列研究
4. A severe inflammatory acne was successfully cleared by topical photodynamic therapy mediated with 5-aminolevulinic acid in an refractory aplastic anemia female patient: a case report [C] . Jingyi Huang, Fen Peng, Xiaojing Yang, International Photodynamic Association World Congress;Society of Photo-Optical Instrumentation Engineers;International Photodynamic Association . 2019

机译：通过5-氨基乙酰丙酸介导的局部光动力疗法成功治疗顽固性再生障碍性贫血女性患者严重炎症性痤疮：一例
5. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin [D] . Venkatramani, Rajkumar. 2010

机译：长春新碱，伊非替康，替莫唑胺和贝伐单抗（VIT-B）逐步剂量在患有非造血源性复发或难治性实体瘤的儿童和青少年患者中的I期研究
6. Intravenous gammaglobulins in refractory polymyositis: lower dose for maintenance treatment is effective [O] . S Genevay, A Saudan-Kister, P Guerne 2001

机译：静脉丙种球蛋白治疗难治性多发性肌炎：较低剂量的维持治疗有效
7. Does severe bleeding in HHT patients respond to intravenous bevacizumab? Review of the literature and case series [O] . T. Rosenberg, A.D. Fialla, J. Kjeldsen, 2019

机译：HHT患者的严重出血是否应对静脉内贝伐单抗？审查文献和案例系列

Maintenance dosing of intravenous Bevacizumab in the treatment of severe HHT related bleeding and refractory anemia

著录项

相似文献

相关主题

期刊订阅